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Offspring of mothers with hypertensive disorders during pregnancy (HDP) have 
increased risk of cardiovascular disease (CVD) (1). Whether this is due to a direct intra 
uterine effect, such as maternal inflammation, endothelial dysfunction or poor placentation 
linked pre-eclampsia (PE), or shared genetics or environment, which is more likely to be 
linked to gestational hypertension (GH), remains undetermined (1). Regardless, it is proposed 
that microvascular changes that predate CVD events by decades could play a role  (2). 
Retinal scans are a non-invasive way to directly observe the human microvasculature. We 
therefore examined whether exposure to maternal HDP was associated with retinal 
microvascular features in adolescent offspring in a UK pregnancy cohort. 
We included 1,082 singletons with information on maternal HDP and retinal 
microvasculature at age 13 from the Avon Longitudinal Study of Parents and Children 
(ALSPAC). Ethical approval was granted by the ALSPAC Law and Ethics Committee and 
local research ethics committees. Women without pre-existing hypertension were classified 
with gestational hypertension (GH) if they had systolic blood pressure ≥140 mmHg and/or 
diastolic blood pressure ≥90 mmHg on at least 2 occasions first occurring after 20 gestational 
weeks. Pre-eclampsia (PE) was defined as GH in combination with proteinuria (≥ 30g/dL). 
We compared children of mothers with GH and PE to children of mothers without pre-
existing hypertension. Measures of retinal microvasculature included arteriolar diameters, 
venular diameters, arteriolar length diameter ratio, arteriolar tortuosity, arteriovenous ratio 
and optimality deviance. The multivariable linear regression models adjusted for sex, age at 
retinal scans, and ametropia (Model 1), in addition to maternal age, parity, education, pre-
pregnancy BMI, smoking and grandparental history of CVD (Model 2).  
A total of 159 mothers (15%) had GH, while 18 (2%) had PE. The mean age of the 
children at the time of the retinal scans was 12.8 years (standard deviation 0.2). Maternal GH 
showed modest associations with offspring retinal venular diameter, adjusted mean difference 
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2.62 microns (95% CI: 0.26, 4.98), and arteriovenous ratio, adjusted mean difference -0.02 
(95% CI: -0.04, -0.01) (Table). Similar associations were not observed for PE, with an 
adjusted mean difference of 0.94 microns (95% CI: -5.50, 7.38) for retinal venular diameter, 
and an adjusted mean difference of -0.01 (95% CI: -0.05, 0.04) for arteriovenous ratio 
(Table). There was no strong evidence of any additional associations. Excluding children 
with childhood-onset diabetes (N=3), did not change results.  
Our findings indicate that children born to mothers with GH (but not PE) have a 
greater venular diameter and a lower arteriovenous ratio. In contrast to findings from the 
Generation R cohort which examined children at age six, our findings do not support a 
narrower arteriolar diameter among children exposed to HDP (3). The differences between 
our findings and those from Generation R may be explained by the fact that they measured 
retinal microvasculature at age 6 instead of age 13, or the fact that they did not separate GH 
from PE, as they grouped both conditions into HDP. However, both narrower arterioles and 
wider venules are known to predict future hypertension and CVD events (4). It is therefore 
plausible that there might be a microvascular pathway linking HDP and increased CVD risk 
in offspring (4). The associations of maternal GH - but not of PE - with offspring 
cardiovascular health are also in line with associations previously reported for offspring 
blood pressure in ALSPAC (5). A potential explanation may be that GH is more likely driven 
by underlying genetic predisposition and lifestyle characteristics, whilst PE is driven by a 
specific pregnancy profile, e.g. placentation.  In conclusion, our results indicate that children 
of mothers with GH have a wider venular diameter and lower arteriovenous ratio. This might 
be explained by a common role of genetic or lifestyle characteristics linked to CVD risk. 
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Table The mean difference in measures of retinal microvasculature between offspring of 
mothers with hypertensive disorders during pregnancy and offspring of normotensive 
mothers  
(n=1,082) 
 
Measure of 
microvasculature 
Gestational hypertension 
Mean difference (95% 
CI) 
Pre-eclampsia 
Mean difference (95% 
CI) 
Direction of the 
association 
between the 
microvascular 
measures and later 
cardiovascular risk 
Arteriolar diameter, 
microns 
  ↓ 
Model 1  0.19 (-1.60, 1.98) 0.42 (-4.52, 5.35)  
Model 2  0.27 (-1.57, 2.12) 0.93 (-4.10, 5.97)  
Venular diameter, 
microns 
  ↑ 
Model 1  3.08 (0.78, 5.37)  1.25 (-5.08, 5.57)  
Model 2  2.62 (0.26, 4.98) 0.94 (-5.50, 7.38)  
Arteriolar length 
diameter ratio (LDR) 
  ↑ 
Model 1  -0.37 (-0.93, 0.19) -0.83 (-2.37, 0.72)  
Model 2  -0.39 (-0.97, 0.18) -0.95 (-2.53, 0.62)  
Arteriolar tortuosity   ↓ 
Model 1  -0.002 (-0.006, 0.002) -0.004 (-0.015, 0.007)  
Model 2  -0.001 (-0.006, 0.003) -0.003 (-0.014, 0.009)  
Arteriovenous ratio   ↓ 
Model 1  -0.03 (-0.04, -0.01) -0.01 (-0.06, 0.03)  
Model 2  -0.02 (-0.04, -0.01) -0.01 (-0.05, 0.04)  
Optimality deviancea   ↑ 
Model 1  -0.002 (-0.017, 0.012) 0.009 (-0.032, 0.050)  
Model 2 -0.003 (-0.019, 0.013) 0.008 (-0.034, 0.049)  
 
CI=confidence interval.  
 
Model 1 Adjusted for age, sex and ametropia. 
 
Model 2 Adjusted for age sex and ametropia, in addition to maternal age, parity, education, 
pre-pregnancy BMI, smoking during pregnancy and genetic predisposition to cardiovascular 
disease (parental history of hypertension, stroke or heart disease). 
 
a For a theoretically optimal bifurcation, the optimality ratio should be 0.79, and the 
optimality deviance was calculated as the absolute value of the optimality ratio minus 0.79. 
 
Multiple imputation of missing covariate information conducted using chained equations.  
 
